Abstract
A set of disorders known collectively as cancers are connected to unnatural cell proliferation. Without any intervention, the illness could worsen, resulting in premature death. A lethal malignant tumor is threatened invasion. Pancreatic cancer (PC) is more frequently found in men and elder persons (60–85 years old). Young individuals are recently being identified with PC more frequently. Being one of the deadliest tumors, it has no earliest symptoms and it can quickly infect nearby tissues and organs. Despite significant advancements in the struggle against the disease, continued, intense efforts are made to promote early detection and treatments. Nanomaterials have gained more attentiveness recently for PC diagnosis and treatment. The most recent information about PC risk, diagnostics, and therapy, as well as the role of polymeric NPs (PNPs) in PC treatment and diagnosis are discussed in this chapter. PNPs synthesis and characterization techniques are also discussed. PNPs have the capability to give improvements in early diagnosis, therapeutic monitoring, and image-guided surgery. Drug delivery using PNP increases tumor targeting penetration, targeted and specific drug delivery, and antitumor activity, enhances the stability and biological uptake of the drugs, and reduces cytotoxicity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Recent Advances in Nanocarriers for Pancreatic Cancer Therapy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
